BioCardia Files 8-K: Other Events & Exhibits
Ticker: BCDA · Form: 8-K · Filed: Jun 7, 2024 · CIK: 925741
| Field | Detail |
|---|---|
| Company | Biocardia, Inc. (BCDA) |
| Form Type | 8-K |
| Filed Date | Jun 7, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 B |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 8-k, corporate-update
TL;DR
BioCardia dropped an 8-K on 6/7 for other events and exhibits.
AI Summary
BioCardia, Inc. filed an 8-K on June 7, 2024, reporting an "Other Events" and "Financial Statements and Exhibits" filing. The company, formerly known as Tiger X Medical, Inc., is incorporated in Delaware and based in Sunnyvale, California.
Why It Matters
This filing indicates BioCardia is providing updates on significant events and financial information to the SEC, which is crucial for investors to stay informed about the company's status.
Risk Assessment
Risk Level: low — This is a routine SEC filing reporting events and exhibits, not a direct financial event or material change.
Key Players & Entities
- BioCardia, Inc. (company) — Registrant
- June 7, 2024 (date) — Date of earliest event reported
- Tiger X Medical, Inc. (company) — Former company name
- Delaware (jurisdiction) — State of incorporation
- Sunnyvale, California (location) — Business address
FAQ
What specific 'Other Events' are being reported by BioCardia, Inc. in this 8-K filing?
The filing indicates 'Other Events' as an item information, but the specific details of these events are not provided in the excerpt.
What types of 'Financial Statements and Exhibits' are included in this 8-K filing?
The filing lists 'Financial Statements and Exhibits' as an item information, but the specific contents are not detailed in the provided text.
When was BioCardia, Inc. previously known by another name?
BioCardia, Inc. was formerly known as Tiger X Medical, Inc., with a date of name change on 20110616.
What is BioCardia, Inc.'s IRS Employer Identification Number?
BioCardia, Inc.'s IRS Employer Identification Number is 23-2753988.
Where is BioCardia, Inc. headquartered?
BioCardia, Inc. is headquartered at 320 Soquel Way, Sunnyvale, California, 94085.
Filing Stats: 460 words · 2 min read · ~2 pages · Grade level 10.1 · Accepted 2024-06-07 07:00:21
Key Financial Figures
- $0.001 B — h registered Common Stock , par value $0.001 BCDA The Nasdaq Capital Market Warrant
Filing Documents
- bcda20240607_8k.htm (8-K) — 28KB
- ex_685196.htm (EX-99.1) — 11KB
- 0001437749-24-019535.txt ( ) — 187KB
- bcda-20240607.xsd (EX-101.SCH) — 4KB
- bcda-20240607_def.xml (EX-101.DEF) — 13KB
- bcda-20240607_lab.xml (EX-101.LAB) — 17KB
- bcda-20240607_pre.xml (EX-101.PRE) — 13KB
- bcda20240607_8k_htm.xml (XML) — 5KB
01 Other Events
Item 8.01 Other Events. On June 7, 2024, BioCardia, Inc. (the "Company") issued a press releases announcing the issuance of U.S. Patent No: 11,986,611 titled "Radial and Transendocardial Delivery Catheter," with a patent term that will expire in 2036. The present invention relates to medical methods suitable for substance delivery to the heart via a radial artery and for the intracardiac delivery of cellular aggregates and other agglomerated materials. A copy of the press release is attached hereto as Exhibit 99.1 to this current report on Form 8-K.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit Number Description 99.1 BioCardia, Inc. press release dated June 7, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL Document.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. BIOCARDIA, INC. /s/ Peter Altman, Ph.D. Peter Altman, Ph.D. President and Chief Executive Officer Date: June 7, 2024